# Filing Detail

Form PRER14A - Preliminary Proxy Soliciting materials:
SEC Accession No. 0001140361-22-022407
Filing Date
2022-06-09
Accepted
2022-06-09 06:04:00
Documents
8

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRER14A | ny20004078x6_prer14a.htm | PRER14A | 6898777
2 |  | logo_centerviewpartnersv2.jpg | GRAPHIC | 20936
3 |  | logo_neogen.jpg | GRAPHIC | 30841
4 |  | ny20004078x6_flowchart01.jpg | GRAPHIC | 70366
5 |  | ny20004078x6_flowchart02.jpg | GRAPHIC | 108364
6 |  | ny20004078x6_flowchart03.jpg | GRAPHIC | 111789
7 |  | ny20004078x6_piechart01.jpg | GRAPHIC | 64155
8 |  | ny20004078x6_piechart02.jpg | GRAPHIC | 47573
| Complete submission text file | 0001140361-22-022407.txt |  | 7523875

Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: PRER14A | Act: 34 | File No.: 000-17988 | Film No.: 221004874
SIC: 2835 In Vitro & In Vivo Diagnostic Substances